Close Menu
    What's Hot

    Hantavirus probe deepens after deaths on Atlantic cruise

    May 4, 2026

    GCC beats global average in 2026 economic freedom index

    May 2, 2026

    UAE and France hold talks on regional stability

    May 1, 2026
    Dehradun GazetteDehradun Gazette
    • Automotive
    • Business
    • Editorial
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Dehradun GazetteDehradun Gazette
    Home » Biolog Enters the European Diagnostic Market, Bringing 45 Years of Anaerobic Culture Excellence
    ACCESS Newswire

    Biolog Enters the European Diagnostic Market, Bringing 45 Years of Anaerobic Culture Excellence

    July 29, 2025
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    Biolog, a leading provider of microbial identification and phenotypic characterization tools and services, announced today that both its anaerobic media and anaerobic chambers have received CE marking, clearing the way for broader international use

    HAYWARD, CALIFORNIA / ACCESS Newswire / July 29, 2025 / Biolog, a leading provider of microbial identification and phenotypic characterization tools and services, announced today that both its anaerobic media and anaerobic chambers have received CE marking, clearing the way for broader international use. The media and chambers were part of Biolog’s acquisition of Anaerobe Systems earlier this year with the objective of bringing class-leading tools for microbiology to the rapidly growing clinical, microbiome, and agricultural markets.

    Today, Biolog’s TruPRAS™ media is the only commercial media manufactured under true pre-reduced, anaerobically sterilized conditions, preventing the formation of harmful byproducts that can be toxic to anaerobic organisms. This line of media products, which has been approved for In Vitro Diagnostic (IVD) use by the USA FDA for years, has now also achieved CE marking under the requirements of the EU IVDR regulation 2017/746. With zero recalls or field actions throughout their extensive history, these products enable transport of specimens and growth of fastidious anaerobes that play important roles in disease pathology – supporting clinical diagnostics in medical laboratories.

    “The IVDR/CE mark is a major milestone that recognizes the high standard of our anaerobic media and its value in supporting critical diagnostic workflows,” said Robert Wicke, CEO at Biolog. “We’re proud that clinical labs throughout Europe can now benefit from the same reliable performance that researchers and clinicians in the U.S. have trusted for decades.”

    Biolog’s anaerobic chambers have also received the CE mark, affirming their safety and performance for use in any research settings throughout the world. With unique InstaSleeve™ technology, these ergonomic, gloveless chambers offer superior processing dexterity while working in a fully anaerobic environment and are a preferred tool for microbiologists in both clinical and academic settings. In addition, Biolog is releasing an upgrade to enable hypoxic or microaerophilic conditions in the same chamber, for organisms that require specific, low concentrations of oxygen to thrive.

    “This dual achievement reinforces Biolog’s commitment to advancing global access to high-quality tools for anaerobic microbiology,” said Wicke. “Whether you’re working with challenging clinical isolates or conducting fundamental research, Biolog now provides dependable CE-marked solutions that meet your needs.”

    About Biolog

    Biolog offers tools, services, and support for comprehensive cellular characterization and multi-omic identification of bacteria, yeast, and fungi. Our products also enable phenotypic profiling of microbial and mammalian cells for a range of applications, including supporting the culture of fastidious anaerobes with our line of gloveless chambers and pre-reduced media. Learn more at biolog.com

    Contact Information

    John Proctor, Ph.D.
    CCO
    jproctor@biolog.com
    (408)306-0414

    SOURCE: Biolog, Inc.

    View the original press release on ACCESS Newswire

    Related Posts

    Global Nurse Migration Patterns Shift as Europe, Southeast Asia Absorb Growing Share of International Nurses

    April 28, 2026

    Safe Staffing Requires New Models of Care, Not Just More Clinicians, Says Global Taskforce

    March 30, 2026

    Multi-Billion-Dollar Sports Brand U.S. Polo Assn. Launches Global Polo Shirt Campaign: An Icon Born from the Game

    March 26, 2026

    Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

    March 23, 2026

    U.S. Polo Assn. Unveils 2026 Spring-Summer Global Collection, Inspired by Coastal Charleston, South Carolina

    March 19, 2026

    Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 2026

    February 5, 2026
    Latest News

    Hantavirus probe deepens after deaths on Atlantic cruise

    May 4, 2026

    Hantavirus, a rare rodent-borne disease, drove a multinational health response after three reported deaths aboard MV Hondius off Cape Verde.

    GCC beats global average in 2026 economic freedom index

    May 2, 2026

    UAE and France hold talks on regional stability

    May 1, 2026

    CBUAE leaves base rate unchanged at 3.65%

    April 30, 2026

    South Korea retail sales climb 5.6% in March

    April 29, 2026

    UAE India dialogue turns to security and energy

    April 27, 2026

    UAE and Mauritania presidents deepen bilateral ties

    April 27, 2026

    UAE mediation helps Russia and Ukraine swap 386 captives

    April 25, 2026
    © 2026 Dehradun Gazette | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.